Ken Griffin
THNR

Ken Griffin’s Amplify Weight Loss Drug & Treatment ETF THNR Stock Holding History

Ken Griffin’s Portfolio THNR Stock Details THNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$670K Buy
+27,241
New +$694K ﹤0.01% 8592

Other funds holding THNR

GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
GFA
Godfrey Financial Associates Glenmont, New York $131M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Ken Griffin's THNR Position: Q1 2026 in Review

Ken Griffin opened a new position in Amplify Weight Loss Drug & Treatment ETF (THNR) in Q1 2026: 27,241 shares worth $670K. The stake represents ﹤0.01% of the portfolio and ranks #8592 among its holdings.

4 funds tracked by Wall St. Rank hold THNR as of Q1 2026.

  • Ken Griffin held 27,241 shares of Amplify Weight Loss Drug & Treatment ETF worth $670K as of Q1 2026.
  • Amplify Weight Loss Drug & Treatment ETF was a new Ken Griffin position in Q1 2026.
  • Amplify Weight Loss Drug & Treatment ETF made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #8592 holding.
  • 4 funds tracked by Wall St. Rank held Amplify Weight Loss Drug & Treatment ETF as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.